For Immediate Release
Chicago, IL – June 14, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corporation (
MSFT Quick Quote MSFT - Free Report) , NIKE, Inc. ( NKE Quick Quote NKE - Free Report) , Novo Nordisk A/S ( NVO Quick Quote NVO - Free Report) , Caterpillar Inc. ( CAT Quick Quote CAT - Free Report) and General Electric Company ( GE Quick Quote GE - Free Report) . Here are highlights from Friday’s Analyst Blog: Top Analyst Reports for Microsoft, Nike and Novo Nordisk
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft, Nike, and Novo Nordisk. These reports have been hand-picked from the roughly 70 published by our analyst team today.
You can see
all of today’s research reports here >>>
Microsoft have outperformed the S&P 500 in the year-to-date period (+16.2% vs. +14.3%). The Zacks analyst believes that Microsoft is benefiting from the adoption of Azure services amid accelerated global digital transformation. Moreover, solid uptake of new Xbox consoles is aiding top-line expansion.
The company is also witnessing growth in the user base of its different applications, including Microsoft 365 suite and Dynamics. However, Microsoft expects Surface as well as Xbox Content and services revenue to decline in the fiscal fourth quarter, owing to tough year-over-year comparisons.
) read the full research report on Microsoft here >>> Nike’s shares have lost -3.6% over the last six months against the Zacks Shoes and Retail Apparel industry’s loss of -0.8%. But the Zacks analyst believes that Nike has been witnessing strong digital trends, which demonstrates strength in its brands and investments made over the past several years to improve the digital consumer experience.
Nike’s top and bottom lines improved year over year in third-quarter fiscal 2021, while earnings beat estimates for the third time in the fiscal year. Digital sales for the Nike brand improved double digits across North America, Greater China, and APLA along with triple-digit growth in EMEA.
However, the company has been witnessing lower revenues in its wholesale business and Nike-owned stores due to the pandemic-led disruptions. In fact, revenues declined across all the regions, except for Greater China.
) read the full research report on NIKE here >>>
Novo Nordisk have gained 19.6% in the past three months against the Zacks Large Cap Pharmaceuticals industry’s gain of 11.9%. The Zacks analyst believes Victoza, Ozempic, Xultophy and Saxenda have been helping the company maintain momentum. Label expansion of existing drugs is likely to further boost sales.
In 2021, the company will continue to focus on commercial execution while conducting more late-stage clinical studies than ever to meet the needs of the people living with diabetes and other serious chronic diseases. However, lower realized prices in the United States, loss of exclusivity for products in hormone replacement therapy and intensifying competition are likely to impact sales.
) read the full research report on Novo Nordisk here >>>
Other noteworthy reports we are featuring today include Caterpillar and General Electric.
+1,500% Growth: One of 2021’s Most Exciting Investment Opportunities
In addition to the stocks you read about above, would you like to see Zacks’ top picks to capitalize on the Internet of Things (IoT)? It is one of the fastest-growing technologies in history, with an estimated 77 billion devices to be connected by 2025. That works out to 127 new devices per second.
Zacks has released a special report to help you capitalize on the Internet of Things’s exponential growth. It reveals 4 under-the-radar stocks that could be some of the most profitable holdings in your portfolio in 2021 and beyond.
Click here to download this report FREE >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.